Re: Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients with High-risk Prostate Cancer with Rising Prostate-specific Antigen Levels After Primary Local Therapy A Randomized Clinical Trial

Kretschmer Alexander; Tilki Derya

首页> 外文期刊>European urology >Re: Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients with High-risk Prostate Cancer with Rising Prostate-specific Antigen Levels After Primary Local Therapy A Randomized Clinical Trial

【24h】

Re: Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients with High-risk Prostate Cancer with Rising Prostate-specific Antigen Levels After Primary Local Therapy A Randomized Clinical Trial

机译：Re：在原发性局部治疗后，将多西紫杉醇添加到高风险前列腺癌患者患者的患者抗剥夺治疗患者的疗效临床试验后前列腺特异性抗原水平上升

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European urology》 |2019年第3期|共2页
作者
Kretschmer Alexander; Tilki Derya;
展开▼
作者单位

Ludwig Maximilians Univ Munchen Univ Hosp Munich Dept Urol Munich Germany;

Univ Hosp Hamburg Eppendorf Martini Klin Prostate Canc Ctr Hamburg Germany;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献
专利

1. Re: Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients with High-risk Prostate Cancer with Rising Prostate-specific Antigen Levels After Primary Local Therapy A Randomized Clinical Trial [J] . Kretschmer Alexander, Tilki Derya European urology . 2019,第3期

机译：Re：在原发性局部治疗后，将多西紫杉醇添加到高风险前列腺癌患者患者的患者抗剥夺治疗患者的疗效临床试验后前列腺特异性抗原水平上升
2. Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical Trials [J] . Hallemeier Christopher L., Zhang Peixin, Pisansky Thomas M., International Journal of Radiation Oncology, Biology, Physics . 2019,第5期

机译：前列腺癌前列腺癌前列腺抑制后前列腺癌患者接受短期雄激素抑制和外梁辐射治疗：4个NRG肿瘤治疗肿瘤学系的汇总分析随机临床试验
3. Using a surgical prostate-specific antigen threshold of 0.2?ng/mL to define biochemical failure for intermediate- and high-risk prostate cancer patients treated with definitive radiation therapy in the ASCENDE-RT randomized control trial [J] . W. James Morris, Tom Pickles, Mira Keyes Brachytherapy . 2018,第6期

机译：使用＆gt的手术前列腺特异性抗原阈值;0.2≤ng/ ml以定义在Ascende-RT随机调控试验中治疗的中间和高风险前列腺癌患者的生化失败
4. Phase I trial of motexafin-lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer [C] . Diana C. Stripp, Rosemarie Mick, Timothy C. Zhu, Conference on optical methods for tumor treatment and detection: Mechanisms and techniques in photodynamic therapy . 2004

机译：Matexafin-Lutetium介导的患者局部复发前列腺癌患者的术语I阶段试验
5. Studies on human prostate-specific antigen as a tumor antigen for the immunotherapy of prostate cancer in a mouse model. [D] . Willis, Richard Allen. 2002

机译：人类前列腺特异性抗原作为一种肿瘤抗原的免疫模型在小鼠模型中的研究。
6. Phase II Study of Neoadjuvant Chemotherapy with Docetaxel and Bevacizumab in Patients with High-Risk Localized Prostate Cancer: A Prostate Cancer Clinical Trials Consortium Trial [O] . Robert W Ross, Matthew D Galsky, Phil Febbo, -1

机译：患者新辅助化疗多西紫杉醇及贝伐单抗的II期临床研究高风险局限性前列腺癌：前列腺癌的临床试验联盟试用
7. Predictors of mortality after androgen-deprivation therapy in patients with rapidly rising prostate-specific antigen levels after local therapy for prostate cancer [O] . Neesha A. Rodrigues, Ming-Hui Chen, William J. Catalona, 2006

机译：雄激素剥夺治疗后的死亡率预测因子患者在前列腺癌局部治疗后的前列腺特异性抗原水平迅速上升

Re: Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients with High-risk Prostate Cancer with Rising Prostate-specific Antigen Levels After Primary Local Therapy A Randomized Clinical Trial

著录项

相似文献

相关主题

期刊订阅